MedTrace Logo

The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System

NCT02136004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2017-10-27

Study results available
· View outcomes & findings →

Summary

The objective of this trial is to demonstrate the safety and effectiveness of the Rex Medical Closer Vascular Sealing System in sealing femoral arterial access sites.

Conditions

  • Surgical Wound

Interventions

DEVICE

Closer VSS

At the end of a percutaneous endovascular procedure, the femoral arterial access site is closed with the Closer device to achieve arterial hemostasis.

Sponsors & Collaborators

  • Rex Medical

    lead INDUSTRY

Principal Investigators

  • Shing-Chiu Wong, MD · New York Presbyterian Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136004 on ClinicalTrials.gov